Invention Application
- Patent Title: CCR4 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF CCR4 POSITIVE MALIGNANCIES
-
Application No.: US17612794Application Date: 2020-05-22
-
Publication No.: US20220249560A1Publication Date: 2022-08-11
- Inventor: Lihua Elizabeth Budde , Marissa M. Del Real , Stephen Forman
- Applicant: City of Hope
- Applicant Address: US CA Duarte
- Assignee: City of Hope
- Current Assignee: City of Hope
- Current Assignee Address: US CA Duarte
- International Application: PCT/US2020/034389 WO 20200522
- Main IPC: A61K35/17
- IPC: A61K35/17 ; C07K14/725 ; A61P35/00 ; C07K16/28 ; C12N5/0783
Abstract:
Chimeric antigen receptors for use in treating lymphoma-associated C-C chemokine receptor type 4 (CCR4) and other cancers expressing CCR4 are described.
Information query
IPC分类:
